This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Revy, P.
Right arrow Articles by Durandy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Revy, P.
Right arrow Articles by Durandy, A.
Related Collections
Right arrow Genetics & Dysmorphology

PEDIATRICS Vol. 105 No. 3 March 2000, p. e39

ELECTRONIC ARTICLE:
A Syndrome Involving Intrauterine Growth Retardation, Microcephaly, Cerebellar Hypoplasia, B Lymphocyte Deficiency, and Progressive Pancytopenia

Received Jun 29, 1999; accepted Nov 5, 1999.

Patrick Revy*, Meinrad BusslingerDagger , Kei Tashiro§, Fernando Arenzanaparallel , Pascal Pillet, Alain Fischer*, and Anne Durandy*

From the * INSERM U429, Hôpital Necker-Enfants-Malades, Paris; Dagger  Research Institute of Molecular Biology, Vienna, Austria; § Center for Molecular Biology and Genetics, Kyoto University, Sakyo-Ku, Kyoto, Japan; parallel  Institut Pasteur, Paris, France; and  CHU de Bordeaux, France.

We report a new complex syndrome involving profound failure to thrive with severe intrauterine growth retardation, cerebellar abnormalities, microcephaly, a complete lack of B lymphocyte development, and secondary, progressive marrow aplasia. B cell differentiation was found to be blocked at the pro-B cell stage. Although not strictly proven, a genetic origin is likely, according to similar cases reported in the literature.

Three candidate genes, PAX5, encoding B cell-specific activator protein, a factor involved in B cell lineage commitment, stromal cell-derived factor 1, and CXCR4, encoding a chemokine and its receptor, respectively, were thought to be responsible for this disease, given the similarity between the phenotype of the corresponding knock-out mice and the clinical features of the patient. However, the genomic DNA sequences of these 3 genes were normal, and normal amounts of stromal cell-derived factor 1 and CXCR4 were present.

These data strongly suggest that another molecule is involved in early B cell differentiation, hematopoiesis, and cerebellar development in humans.

 Key words:  B lymphocytes, cerebellar hypoplasia, progressive marrow aplasia, PAX5, B cell-specific activator protein, stromal cell-derived factor 1, CXCR4.